期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
康柏西普治疗糖尿病患者白内障术后不同类型黄斑水肿的疗效 被引量:13
1
作者 郑华宾 宫月荣 +2 位作者 曹晓宁 李卫国 张培培 《国际眼科杂志》 CAS 北大核心 2020年第11期1967-1970,共4页
目的:观察康柏西普治疗糖尿病患者白内障术后不同类型黄斑水肿的疗效。方法:选取2017-01/2018-12于我院行白内障超声乳化联合人工晶状体植入术后视力再次下降并确诊为黄斑水肿的糖尿病患者52例52眼。根据黄斑水肿OCT分型,将发生弥漫性... 目的:观察康柏西普治疗糖尿病患者白内障术后不同类型黄斑水肿的疗效。方法:选取2017-01/2018-12于我院行白内障超声乳化联合人工晶状体植入术后视力再次下降并确诊为黄斑水肿的糖尿病患者52例52眼。根据黄斑水肿OCT分型,将发生弥漫性黄斑水肿者18眼纳入DRT组,发生黄斑囊样水肿者20眼纳入CME组,发生浆液性视网膜脱离者14眼纳入SRD组,均按照1+PRN方案行玻璃体腔注射康柏西普。治疗(首次玻璃体腔注射)后随访12mo,观察并比较各组患者最佳矫正视力(BCVA)、黄斑中心凹视网膜厚度(CMT),并记录药物注射次数。结果:三组患者治疗前BCVA和CMT无明显差异,但DRT组黄斑水肿发病时间明显短于CME组和SRD组(P<0.05)。治疗后1mo,三组患者BCVA和CMT均明显好转,且治疗后3mo起,三组患者BCVA和CMT继续好转并逐渐稳定,与治疗前比较均明显改善(P<0.05)。治疗后1、3、6、12mo,DRT组和CME组患者BCVA和CMT均好于SRD组(P<0.05),但DRT组与CME组之间无明显差异(均P>0.05)。三组患者药物注射次数分别为3.2±0.9、2.9±0.8、4.1±1.1次,SRD组注射次数明显多于DRT组和CME组(均P<0.05)。结论:糖尿病患者白内障术后黄斑水肿应早期干预,康柏西普可以有效改善白内障术后不同类型黄斑水肿患者的视力,减轻黄斑水肿。 展开更多
关键词 康柏西普 糖尿病 白内障 黄斑水肿 玻璃体腔注射
暂未订购
Preoperative evaluation and outcome of corneal transplantation for limbal dermoids:aten-yearfollow-up study 被引量:1
2
作者 Meng Xin yue-rong gong +3 位作者 Shan-Hao Jiang Chun-Hua Dai Su-Xia Li Wei-Yun Shi 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2016年第12期1756-1760,共5页
AIM: To summarize preoperative evaluation and outcome of corneal transplantation for limbal dermoids for ten years.METHODS: Eighty-five patients diagnosed with limbal dermoids and treated with corneal transplantatio... AIM: To summarize preoperative evaluation and outcome of corneal transplantation for limbal dermoids for ten years.METHODS: Eighty-five patients diagnosed with limbal dermoids and treated with corneal transplantation were analyzed retrospectively. All patients were further divided into two groups according to absence or presence of neovascularization surrounding the dermoids in the corneal stroma. Eighty-two eyes were treated with tumor excision combined with partial lamellar sclerokeratoplasty, and the other three eyes were performed by penetrating keratoplasty. The size and location of the tumor, the associated ocular and systemic anomalies, the depth of the corneal penetration of tumor tissues, the preoperative and postoperative best-corrected visual acuity (BCVA), graft survival and cosmetic outcome, and surgical complications were recorded respectively.RESULTS: The average age at surgery was 5.3y (range, 3mo-36y). The mean size of dermoids was 6.1±1.6 mm. The 43.5% of eyes (37/85) were present with hair at the surface of the dermoid and 72.9% of dermoids were located inferotemporal of the eye. Amplyopia was present in 34.1% of patients (29/85) and 9.4% of patients (8/85) had lipodermoids. Eighteen patients suffered from Goldenhar’s syndrome with an accessory ear. The 75% of patients in group 1 had involvement of the corneal deep stroma down to Descemet’s membrane without involving it, but 71.4% of patients had Descemet’s membrane involvement in group 2. Preoperative BCVA ranged from counting fingers to 20/20. Postoperatively 81.1% had a BCVA of 20/800 or better. There was no significant difference between the post-surgical BCVA of the two groups (t=1.584, P〉0.05). The grafts of 70.5% patients were present as 1+ opacity, 21.1% as 2+ opacity, 8.2% as 3+ opacity and none as 4+ opacity. Surgical complications included graft rejection, microperforation, prolonged reepithelialization, steroid glaucoma, interface neovascularization, and interface hemorrhage.CONCLUSION: The dermoids with neovascularization surrounding them in the corneal stroma invaded deeper tissues in the cornea than those with no neovascularization surrounding them in the corneal stroma. Therefore, surgeons should take care to avoid corneal perforation during the corneal transplantation operation. The majority of patients markedly improved their cosmetic appearance after surgery. 展开更多
关键词 limbal dermoids corneal transplantation NEOVASCULARIZATION
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部